CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Mycori›
Analysis
Mycori

Mycori

Mycori develops a 100 percent natural mushroom-based leather alternative for industries that currently rely on animal leather.

Zurich, CH🇨🇭
Founded
2023
Loading
Overview
Analysis
Compare
Employees
Library

Contents

  1. 01Competitive Landscape
  2. 02Market Outlook
  3. 03Risk Factors
  1. 01Competitive Landscape
  2. 02Market Outlook
  3. 03Risk Factors

Competitive Landscape

Mycori competes in the emerging mycelium- and mushroom-based leather alternatives category, where the most visible named alternative is MycoWorks of California with its Reishi fine mycelium material, alongside firms such as MycoCycle pursuing related routes. Mycori's distinguishing claim is a patented, industrially controlled process that works with locally sourced mushroom fibers to produce a fully bio-based, biodegradable material with high reproducibility, which the 2025 Swiss Design Award Circular Design jury treated as distinct from mycelium- or plant-based alternatives.

For the same buyer — makers replacing animal leather — adjacent substitutes include plant-based and synthetic vegan leathers, so Mycori's trade-off is less scale and market presence than established international players, offset by a locally controlled, customizable production process. The decisive contest is therefore industrial reproducibility and customer access rather than material chemistry, where a young Swiss entrant must win pioneering brands before category leaders consolidate the market.

Source: designpreis.ch

Market Outlook

Mycori's position in mushroom-based leather alternatives is supported by a category in visible motion: as of September 2025 and 2026, industry reporting placed mushroom leather on a path of growing commercial adoption across fashion and materials, while competitors such as MycoWorks secured further demand and adjusted their business models in 2025-2026, a sign of both growing demand and a demanding commercial environment for young entrants.

For Mycori, the outlook therefore hinges on converting its patented process and 2025 Swiss Design Award recognition into industrial-scale customers; if leather-replacement demand keeps rising, its locally sourced, customizable fiber process could gain share in European design and fashion niches, while a consolidation of funding around larger international players would weaken that trajectory.

Source: snsinsider.com

Risk Factors

Mycori's principal risks are concentration and scale: the venture has a single registered board member, founder Hans Peter "Ben" Weinberg, since its August 2023 registration, so execution depends on a very small leadership base. As of January 2025, its mushroom leather was publicly described by the founder as still at an early development stage, which leaves the company exposed to technical maturity risk on top of its commercial one.

A further risk is competitive exposure: better-funded international players dominate category news, so Mycori's mitigants are its registered trademark MYCORI (Swissreg, filed March 2024), its patent-protected process, and its positioning as a customization partner, which are facts, while the inference that these suffice against larger rivals remains an analyst judgment.

Source: moneyhouse.ch